A recent article published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements. Here are the details.
Read More
Imagine receiving a COVID-19 vaccine not from the jab of a needle and syringe but by slipping a thin, clear film smaller than a postage stamp inside your cheek or under your tongue and letting it dissolve. That’s one of the potential benefits of a new drug-delivery technology being developed by a startup company in Chapel Hill.
Read More
The European Society of Gene and Cell Therapy (ESGCT), a nonprofit organization supporting scientists and clinicians, recognized gene therapy pioneer and entrepreneur Jude Samulski, Ph.D., with its inaugural Founders Award.
Read More
Jude Samulski, a pioneer in using small viruses to insert therapeutic genes into cells, has been awarded an international patent application by the World Intellectual Property Organization for his regulated gene-editing system.
Read More
